Cancer sequencing panels are key molecular tools in modern oncology. They make it possible to detect genetic alterations relevant for

Functional ex vivo assays applied to metastatic colon cancer (mCRC) directly evaluate a patient’s tumor response to chemotherapeutic agents before

Oncologic biomarkers are biological measurements that indicate the presence, progression, or response to treatment of a cancer. Their usefulness includes